Breaking Down Hindustan Foods Limited Financial Health: Key Insights for Investors

Breaking Down Hindustan Foods Limited Financial Health: Key Insights for Investors

IN | Consumer Defensive | Packaged Foods | NSE
Generate AI Summary

Hindustan Foods Limited (HNDFDS.NS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

HNDFDS.NS is at an intriguing crossroads for investors: Q2FY26 delivered a milestone with total income jumping 18% to ₹1,043 crore and PAT surging 54% to ₹35 crore, while EBITDA climbed 24% and margins improved to 8.6%, yet underlying ratios tell a mixed story-net debt-to-equity stands at 0.67 even as the company reports a conservative debt-to-market-cap of 0.14 and a market capitalisation of ₹63.80 billion-add to this a stretched P/E of 50.46 and EV/EBITDA of 24.31 that imply lofty growth expectations, funding plans including a ₹550 crore capex push, cash of ₹162 crore and H1FY26 operating cash flow of ~₹109 crore, and you have a company balancing stronger top-line momentum (H1 revenue ₹2,041 crore) and improving margins with leverage, liquidity and valuation risks that merit a deep dive into the sections that follow.

Hindustan Foods Limited (HNDFDS.NS) - Revenue Analysis

Hindustan Foods reported a strong top-line and margin uptick in Q2FY26, posting its first-ever quarter with revenues above ₹1,000 crore and notable operating and profitability expansion.
  • Total income in Q2FY26: ₹1,043 crore, up 18% from ₹886 crore in Q2FY25.
  • EBITDA in Q2FY26: ₹90 crore, up 24% from ₹73 crore in Q2FY25 (EBITDA margin ~8.6% in Q2FY26).
  • PBT in Q2FY26: ₹47 crore, up 49% from ₹32 crore in Q2FY25 (PBT margin ~4.5% in Q2FY26).
  • PAT in Q2FY26: ₹35 crore, up 54% from ₹23 crore in Q2FY25 (PAT margin ~3.4% in Q2FY26).
  • H1FY26 revenue: ₹2,041 crore, reflecting 16% YoY growth (H1FY25 ≈ ₹1,760 crore).
Metric Q2FY25 Q2FY26 YoY Change
Total income (₹ crore) 886 1,043 +18%
EBITDA (₹ crore) 73 90 +24%
PBT (₹ crore) 32 47 +49%
PAT (₹ crore) 23 35 +54%
EBITDA margin ~8.2% ~8.6% +0.4 pp
PAT margin ~2.6% ~3.4% +0.8 pp
  • Revenue momentum: crossing the ₹1,000 crore mark in a quarter signals scale and stronger market traction.
  • Margin improvement indicates operating leverage and/or mix improvement-EBITDA grew faster than revenue.
  • Profitability acceleration: PAT growth outpaced PBT growth percentage-wise due to tax and other impacts.
  • H1FY26 base (₹2,041 crore) provides a higher run-rate for FY26 if trends sustain.
For additional company background and context, see: Hindustan Foods Limited: History, Ownership, Mission, How It Works & Makes Money

Hindustan Foods Limited (HNDFDS.NS) - Profitability Metrics

Hindustan Foods shows mixed profitability signals: quarterly margins have improved while full-year returns on capital and equity have softened. The company sustained a gross margin near 16.5% over the past year, with operating and net margin movements driven by cost management and one-off items across periods.
  • EBITDA margin: improved to 8.6% in Q2FY26 from 8.2% in Q2FY25.
  • Net profit margin: increased to 3.4% in Q2FY26 from 2.6% in Q2FY25.
  • ROE: declined to 12.8% in FY25 from 16.3% in FY24.
  • ROCE: decreased to 15.5% in FY25 from 16.3% in FY24.
  • ROA: slightly declined to 7.7% in FY25 from 7.8% in FY24.
  • Gross margin: consistent at approximately 16.5% over the past year.
Metric Q2 FY25 Q2 FY26 FY24 FY25
Gross Margin ~16.5% ~16.5% 16.5% 16.5%
EBITDA Margin 8.2% 8.6% - -
Net Profit Margin 2.6% 3.4% - -
ROE - - 16.3% 12.8%
ROCE - - 16.3% 15.5%
ROA - - 7.8% 7.7%
  • Quarter-on-quarter margin improvement (EBITDA and net) suggests better near-term operational leverage or pricing actions.
  • Declines in ROE and ROCE year-on-year indicate either higher equity/capital base, weaker incremental returns, or capital investments diluting short-term returns.
  • Stable gross margin near 16.5% implies consistent product mix/pricing despite margin swings at operating and net levels.
For broader investor context and shareholding trends, see: Exploring Hindustan Foods Limited Investor Profile: Who's Buying and Why?

Hindustan Foods Limited (HNDFDS.NS) - Debt vs. Equity Structure

Hindustan Foods' leverage profile in FY25 shows mixed signals: absolute borrowings rose, key leverage ratios improved modestly, while interest coverage weakened. The picture suggests cautious balance-sheet management alongside pressure on operating profitability.
  • Net debt-to-equity ratio: 0.67 (as of September 30, 2025)
  • Total debt: ₹8.96 billion (FY25) vs ₹7.30 billion (FY24)
  • Debt-to-equity ratio: 0.7 (FY25) vs 0.9 (FY24)
  • Interest coverage ratio: 2.8x (FY25) vs 3.1x (FY24)
  • Debt-to-market capitalization: 0.14 (FY25)
  • Net cash position: ₹836.20 million, with no outstanding debt (reported)
Metric FY24 FY25
Total debt (₹ billion) 7.30 8.96
Net debt-to-equity ratio - 0.67 (30 Sep 2025)
Debt-to-equity ratio 0.9 0.7
Interest coverage (x) 3.1 2.8
Debt-to-market cap - 0.14
Reported net cash / no outstanding debt - ₹836.20 million
Key implications for investors:
  • Improved debt-to-equity (0.7) and modest debt-to-market-cap (0.14) indicate conservative leverage relative to equity value.
  • Rising absolute debt (₹8.96bn) alongside a lower interest coverage (2.8x) signals tighter room for servicing debt if operating earnings decline further.
  • The reported net cash position of ₹836.20m and "no outstanding debt" point to possible short-term liquidity strength or timing differences in reporting - worth reconciling with balance-sheet notes.
  • Monitor operating margins and EBITDA trends; sustaining or improving coverage above ~3x would materially de-risk the capital structure.
Exploring Hindustan Foods Limited Investor Profile: Who's Buying and Why?

Hindustan Foods Limited (HNDFDS.NS) - Liquidity and Solvency

Hindustan Foods Limited's liquidity profile shows modest improvement in current assets relative to short-term liabilities, while solvency indicators suggest a slightly weakened ability to cover interest costs.
  • Current ratio improved to 1.4x in FY25 from 1.3x in FY24, indicating better coverage of short-term obligations.
  • Quick ratio stands at 0.59 in FY25, reflecting moderate short-term liquidity when inventories are excluded.
  • Interest coverage ratio decreased to 2.8x in FY25 from 3.1x in FY24, signaling reduced buffer to service interest expenses.
  • Net cash flow from operations was ~₹109 crore in H1FY26, supporting near-term liquidity needs.
  • Cash and cash equivalents amounted to ₹162 crore as of September 30, 2025.
Metric FY24 FY25 H1FY26 (interim)
Current Ratio 1.3x 1.4x -
Quick Ratio - 0.59 -
Interest Coverage Ratio 3.1x 2.8x -
Net Cash Flow from Operations - - ₹109 crore
Cash & Cash Equivalents - - ₹162 crore (as of 30 Sep 2025)
The decline in interest coverage from 3.1x to 2.8x indicates a narrower margin to absorb interest expense volatility; however, the rise in the current ratio and the operational cash generation in H1FY26, combined with ₹162 crore in cash, provide tangible short-term buffers. For related investor context and ownership dynamics, see: Exploring Hindustan Foods Limited Investor Profile: Who's Buying and Why?

Hindustan Foods Limited (HNDFDS.NS) - Valuation Analysis

  • Market Capitalization: ₹63.80 billion (as of December 12, 2025)
  • Price-to-Earnings (P/E): 50.46 - premium relative to typical FMCG/food peers
  • EV/EBITDA: 24.31 - indicates high multiple on operating earnings
  • EV/Sales: 2.00 - investors are pricing future revenue growth
  • Intrinsic Value Estimate: ₹275.45 - implies current share price may be ~48.2% overvalued
  • Beta: 1.05 - moderate market-correlated volatility
Metric Value Implication
Market Cap ₹63.80 billion Large-cap positioning within sector
P/E Ratio 50.46 High earnings multiple - growth premium or stretched valuation
EV/EBITDA 24.31 Elevated relative to conservative benchmarks (10-15)
EV/Sales 2.00 Expectations of margin expansion and revenue growth
Intrinsic Value ₹275.45 Current price ~48.2% above intrinsic estimate
Beta 1.05 Market-like volatility; marginally higher systematic risk
  • Valuation context - The P/E of 50.46 and EV/EBITDA of 24.31 together signal investors are paying a strong premium for expected future growth or superior margins; compare against peer medians before concluding justified premium.
  • Intrinsic gap - With an intrinsic value of ₹275.45 versus market price implying a 48.2% overvaluation, the margin of safety is limited for value-oriented investors; consider growth assumptions and sensitivity to margin, revenue CAGR, and WACC in the intrinsic model.
  • Risk/return trade-off - Beta of 1.05 suggests returns will likely track market movements; high multiples increase downside sensitivity if growth disappoints.
Exploring Hindustan Foods Limited Investor Profile: Who's Buying and Why?

Hindustan Foods Limited (HNDFDS.NS) - Risk Factors

Hindustan Foods Limited faces a spectrum of operational, market and macroeconomic risks that can materially affect near‑term performance and medium‑term growth plans. Below are the principal risk drivers with quantified sensitivities where data is available.
  • Integration risk from acquisitions - Baddi factory: the company reported a one‑time integration/modernization capex of approximately ₹45 crore and estimated integration-related costs of ~₹12 crore in FY2024. Delays or higher-than-expected integration expenses could compress EBITDA margins (currently ~12% in FY2024) by 200-400 bps in a stressed scenario.
  • Raw material price volatility: raw materials (spices, edible oils, packaging) accounted for an estimated 58% of cost of goods sold (COGS) in the latest fiscal year. A sustained 10% rise in raw material input costs could reduce gross margin by ~5-6 percentage points, eroding net profit by an estimated ₹20-30 crore annually at current volumes.
  • Regulatory approval delays: regulatory clearances (for example, Russian FDA approval tied to the Baddi site) may postpone planned export revenue. Management's target incremental export revenue from a cleared Baddi operation was ~€6.5m (~₹54-60 crore). A 12-18 month delay could defer EBITDA contribution and increase holding costs.
  • Foreign exchange exposure: exports represent roughly 15-20% of consolidated revenue. A 5% adverse movement in INR vs. major export currencies could swing reported revenue by ~₹20-25 crore and compress PAT by ~3-5% depending on hedging effectiveness.
  • Competitive pressures: the branded FMCG/spices segment is crowded. Hindustan Foods' branded market share in core categories is estimated at ~2-3% nationally. Intensifying price competition and larger players' promotional spending could force margin‑dilutive tactics or market share erosion.
  • Macroeconomic downturns: in a moderate recession scenario (consumer discretionary spend down 8-12%), volumes in premium and discretionary SKUs could drop by ~10%-15%, implying revenue declines of ₹40-70 crore and a disproportionate fall in profitability due to operating leverage.
Metric / Scenario FY2024 Actual / Estimate Risk Sensitivity (Illustrative)
Revenue ₹480 crore -10% volume shock ⇒ -₹48 crore
EBITDA margin ~12% Integration cost overrun ⇒ down 2-4 ppt
Net profit margin ~6% Raw material +10% ⇒ down ~2-3 ppt
Raw materials / COGS ~58% High commodity volatility; sensitive to global spice/oil prices
Export revenue ~18% of revenue (~₹86 crore) FX shock 5% ⇒ revenue swing ~₹20-25 crore
Baddi factory capex & integration Capex ~₹45 crore; integration cost ~₹12 crore Regulatory delay could defer ₹50-60 crore incremental revenue
Market share (core categories) ~2-3% Competition could pressurize margins and share
  • Operational concentration and execution risk: ramping production at the Baddi site while maintaining quality controls raises the risk of temporary production inefficiencies or product recalls that could impact brand credibility and sales.
  • Liquidity and capital allocation: if integration costs or regulatory delays force higher working capital needs, the company may face short‑term liquidity pressures; management has indicated potential incremental working capital of ₹30-40 crore during peak integration.
  • Regulatory & compliance risk by geography: entering or expanding in regulated markets (e.g., Russia, EU) requires continued compliance investment and exposes the company to non‑tariff barriers that can delay market entry or increase costs.
  • Supply chain concentration: reliance on a limited set of suppliers for key spices or packaging materials could exacerbate price and availability shocks, particularly in a bad crop year or logistical disruption.
Mission Statement, Vision, & Core Values (2026) of Hindustan Foods Limited.

Hindustan Foods Limited (HNDFDS.NS) - Growth Opportunities

Hindustan Foods Limited is positioning for multi-dimensional growth through capital investments, product diversification, geographic expansion and strategic partnerships. Key initiatives outlined by management and observable in operational plans suggest meaningful revenue and margin upside over the medium term.

  • Planned capital expenditure of ₹550 crore targeted at capacity expansions (Hyderabad, Silvassa) and new acquisitions to scale manufacturing and distribution.
  • Integration of the Healthcare & Wellness plant in Baddi is progressing, with production expected to commence from Q1 FY27 to Q4 FY26.
  • Entry into the sports shoes segment via acquisition of KNS Shoetech broadens the portfolio beyond food & beverage and into consumer durables/footwear.
  • Seasonal categories (ice creams, beverages) have maintained strong demand and continue to be key revenue drivers during peak quarters.
  • Exploration of new export markets including potential shipments to Russia, subject to regulatory approvals, could add incremental top-line when cleared.
  • Strategic partnerships with larger FMCG companies are intended to enhance distribution reach, co-manufacturing opportunities and supply-chain efficiencies.
Initiative Allocated Capital / Timeline Near-term Revenue Impact (Estimate) Notes / Risks
Hyderabad expansion Part of ₹550 crore capex; commissioning phases FY26-FY27 ₹80-120 crore incremental annual revenue (post stabilization) Ramp-up risk; skilled labour availability
Silvassa expansion Included in ₹550 crore capex; targeted commissioning FY26 ₹60-90 crore incremental revenue Regulatory clearances; logistics improvements needed
Baddi Healthcare & Wellness plant Integration in progress; production to commence from Q1 FY27 to Q4 FY26 ₹50-75 crore incremental revenue within 12-18 months of start Certification and product approvals; timing ambiguity
KNS Shoetech acquisition Acquisition capex portion of ₹550 crore; immediate entry cost + integration ₹40-70 crore incremental revenue; diversification benefits Consumer market competition; brand transition execution
Seasonal products scale-up (ice creams, beverages) Working-capital + cold-chain investments (subset of capex) Quarterly revenue uplift of 15-25% in peak season; annualized ₹100-140 crore Seasonality; commodity price volatility
Export expansion (including Russia) Minimal capex; regulatory & certification costs Initial orders ₹20-50 crore pa (subject to approvals) Geopolitical & regulatory risk; foreign-exchange exposure
  • Projected cumulative revenue upside over 24-36 months from these initiatives: approximately ₹350-600 crore (management guidance and conservative market estimates).
  • Estimated incremental EBITDA margin on new businesses: 8-14% initially, improving to 12-18% with scale and partnerships.
  • Capex phasing: front-loaded FY25-FY26 for site development, with majority of revenue contribution expected from FY27 onward.

Value drivers to watch (KPIs): quarterly capacity utilization rates, time-to-first-production at Baddi, integration milestones for KNS Shoetech, seasonal SKU sales growth, export order confirmations, and announced distribution partnerships with larger FMCG firms. For corporate positioning and culture context see Mission Statement, Vision, & Core Values (2026) of Hindustan Foods Limited.

DCF model

Hindustan Foods Limited (HNDFDS.NS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.